PMC:7594251 / 65476-65617
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T468 | 15-16 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T469 | 70-73 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T470 | 109-110 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T60398 | 129-133 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T448 | 0-141 | Sentence | denotes | These are just a few examples to show that diffusion NMR spectroscopy has played, and will continue to play, a prominent role in drug design. |